Medigus Ltd ADR
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $3.79
- Today's High:
- $3.89
- Open Price:
- $3.79
- 52W Low:
- $3.7
- 52W High:
- $9.7881
- Prev. Close:
- $3.9
- Volume:
- 5117
Company Statistics
- Market Cap.:
- $6.64 million
- Book Value:
- 23.807
- Revenue TTM:
- $91.86 million
- Operating Margin TTM:
- -9.34%
- Gross Profit TTM:
- $4.80 million
- Profit Margin:
- -10.69%
- Return on Assets TTM:
- -6.82%
- Return on Equity TTM:
- -19.24%
Company Profile
Medigus Ltd ADR had its IPO on 2015-08-05 under the ticker symbol MDGS.
The company operates in the Healthcare sector and Medical Devices industry. Medigus Ltd ADR has a staff strength of 77 employees.
Stock update
Shares of Medigus Ltd ADR opened at $3.79 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $3.79 - $3.89, and closed at $3.85.
This is a -1.28% slip from the previous day's closing price.
A total volume of 5,117 shares were traded at the close of the day’s session.
In the last one week, shares of Medigus Ltd ADR have increased by +1.05%.
Medigus Ltd ADR's Key Ratios
Medigus Ltd ADR has a market cap of $6.64 million, indicating a price to book ratio of 0.2313 and a price to sales ratio of 0.2558.
In the last 12-months Medigus Ltd ADR’s revenue was $91.86 million with a gross profit of $4.80 million and an EBITDA of $-5385000. The EBITDA ratio measures Medigus Ltd ADR's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Medigus Ltd ADR’s operating margin was -9.34% while its return on assets stood at -6.82% with a return of equity of -19.24%.
In Q2, Medigus Ltd ADR’s quarterly earnings growth was a positive 0% while revenue growth was a positive 636.6%.
Medigus Ltd ADR’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
- 0
Its diluted EPS in the last 12-months stands at $-6.36 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Medigus Ltd ADR’s profitability.
Medigus Ltd ADR stock is trading at a EV to sales ratio of 0.0058 and a EV to EBITDA ratio of -0.0132. Its price to sales ratio in the trailing 12-months stood at 0.2558.
Medigus Ltd ADR stock pays annual dividends of $0 per share, indicating a yield of 21.04% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $97.65 million
- Total Liabilities
- $37.63 million
- Operating Cash Flow
- $-394500.00
- Capital Expenditure
- $10000
- Dividend Payout Ratio
- 0%
Medigus Ltd ADR ended 2024 with $97.65 million in total assets and $0 in total liabilities. Its intangible assets were valued at $97.65 million while shareholder equity stood at $39.14 million.
Medigus Ltd ADR ended 2024 with $0 in deferred long-term liabilities, $37.63 million in other current liabilities, in common stock, $-85586000.00 in retained earnings and $9.07 million in goodwill. Its cash balance stood at $20.07 million and cash and short-term investments were $25.05 million. The company’s total short-term debt was $6,742,000 while long-term debt stood at $0.
Medigus Ltd ADR’s total current assets stands at $52.26 million while long-term investments were $0 and short-term investments were $4.99 million. Its net receivables were $25.23 million compared to accounts payable of $20.42 million and inventory worth $1.79 million.
In 2024, Medigus Ltd ADR's operating cash flow was $-394500.00 while its capital expenditure stood at $10000.
Comparatively, Medigus Ltd ADR paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $3.85
- 52-Week High
- $9.7881
- 52-Week Low
- $3.7
- Analyst Target Price
- $
Medigus Ltd ADR stock is currently trading at $3.85 per share. It touched a 52-week high of $9.7881 and a 52-week low of $9.7881. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $4.27 and 200-day moving average was $4.8 The short ratio stood at 0.71 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 154.1% are held by institutions.
Frequently Asked Questions About Medigus Ltd ADR
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.